Pensionfund Sabic Decreases Position in The Clorox Company (NYSE:CLX)


Share on StockTwits

Pensionfund Sabic decreased its position in shares of The Clorox Company (NYSE:CLX) by 9.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,500 shares of the company’s stock after selling 1,000 shares during the period. Pensionfund Sabic’s holdings in The Clorox were worth $1,832,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Iron Horse Wealth Management LLC acquired a new position in shares of The Clorox in the fourth quarter valued at approximately $25,000. McCarthy Asset Management Inc. acquired a new position in shares of The Clorox in the fourth quarter valued at approximately $38,000. Fort Pitt Capital Group LLC acquired a new position in shares of The Clorox in the fourth quarter valued at approximately $40,000. Oder Investment Management LLC acquired a new position in shares of The Clorox in the fourth quarter valued at approximately $43,000. Finally, Advisory Alpha LLC acquired a new position in shares of The Clorox in the third quarter valued at approximately $46,000. 81.73% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have recently issued reports on CLX. Morgan Stanley dropped their target price on The Clorox from $190.00 to $182.00 and set an “underweight” rating on the stock in a report on Thursday, January 14th. Smith Barney Citigroup upgraded The Clorox from a “neutral” rating to a “buy” rating and lifted their price target for the company from $238.00 to $249.00 in a research note on Monday, December 14th. Bank of America decreased their price target on The Clorox from $245.00 to $235.00 and set a “neutral” rating on the stock in a research note on Friday, January 22nd. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upgraded The Clorox from a “neutral” rating to a “buy” rating and lifted their price target for the company from $238.00 to $249.00 in a research note on Sunday, December 13th. Finally, Wells Fargo & Company restated a “buy” rating and issued a $240.00 price target on shares of The Clorox in a research note on Wednesday, February 10th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company’s stock. The Clorox has an average rating of “Hold” and an average price target of $216.65.

In other news, COO Eric H. Reynolds sold 3,147 shares of the stock in a transaction dated Monday, January 25th. The stock was sold at an average price of $214.07, for a total value of $673,678.29. Following the completion of the sale, the chief operating officer now owns 16,997 shares in the company, valued at $3,638,547.79. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Kevin B. Jacobsen sold 35,176 shares of the stock in a transaction dated Monday, January 25th. The shares were sold at an average price of $215.00, for a total value of $7,562,840.00. Following the completion of the sale, the chief financial officer now owns 26,491 shares of the company’s stock, valued at approximately $5,695,565. The disclosure for this sale can be found here. Corporate insiders own 1.09% of the company’s stock.

The Clorox stock opened at $194.00 on Thursday. The firm has a market capitalization of $24.40 billion, a P/E ratio of 21.60, a PEG ratio of 3.39 and a beta of 0.21. The stock has a fifty day moving average price of $187.51 and a 200 day moving average price of $200.27. The Clorox Company has a 52 week low of $176.73 and a 52 week high of $239.87. The company has a current ratio of 1.41, a quick ratio of 1.06 and a debt-to-equity ratio of 2.12.

The Clorox (NYSE:CLX) last released its earnings results on Wednesday, February 3rd. The company reported $2.03 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.78 by $0.25. The firm had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.75 billion. The Clorox had a return on equity of 132.72% and a net margin of 16.14%. The business’s quarterly revenue was up 27.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.46 earnings per share. As a group, equities analysts predict that The Clorox Company will post 8.03 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 7th. Investors of record on Wednesday, April 21st will be paid a $1.11 dividend. The ex-dividend date is Tuesday, April 20th. This represents a $4.44 annualized dividend and a yield of 2.29%. The Clorox’s payout ratio is currently 60.33%.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

See Also: Trading Strategy Examples and Plans

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.